GILEAD SCIENCES, INC. $500,000,000 2.050% SENIOR NOTES DUE 2019 $1,750,000,000 3.700% SENIOR NOTES DUE 2024 $1,750,000,000 4.800% SENIOR NOTES DUE 2044 Underwriting AgreementUnderwriting Agreement • March 7th, 2014 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
The Securities will be issued pursuant to an Indenture dated as of March 30, 2011 (the “Base Indenture”) between the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee”), as supplemented by a supplemental indenture to be dated as of March 7, 2014 (together with the Base Indenture, the “Indenture”).
